TMCnet News
Research and Markets: Varicella Zoster (HHV-3) Infections - 2015 Pipeline Insights ReportResearch and Markets (http://www.researchandmarkets.com/research/7bsspn/varicella_zoster) has announced the addition of the "Varicella Zoster (HHV-3) Infections-Pipeline Insights" report to their offering. Varicella Zoster (HHV-3) Infections - Pipeline Insights provides the in-depth analysis of the pipeline assets across the Varicella Zoster (HHV-3) Infections. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Varicella Zoster (HHV-3) Infections Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. Varicella Zoster (HHV-3) Infections - Pipelne Insights Report covers the Varicella Zoster (HHV-3) Infections pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Varicella Zoster (HHV-3) Infections related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for Varicella Zoster (HHV-3) Infections. Scope - The report provides a Varicella Zoster (HHV-3) Infections Landscape across the globe - The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information - Coverage of the Varicella Zoster (HHV-3) Infections pipeline on the basis of target, MOA, route of administration, technology involved and molecule type - The report reviews key players involved in the therapeutics development for Varicella Zoster (HHV-3) Infections and also provide company profiling - Pipeline products coverage based on various stages of development from NDA filings to discovery. - Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type For more information visit http://www.researchandmarkets.com/research/7bsspn/varicella_zoster
View source version on businesswire.com: http://www.businesswire.com/news/home/20150804006708/en/ |
